Key result
Overexpression of SDF-1α enhanced cardiac stem cell migration and engraftment, significantly reducing infarcted size to 17.3% compared to 27.3% in the MI control group.
Why the study?
Does overexpression of SDF-1α improve cardiac stem cell migration, engraftment, and reduce infarcted size in a mouse model of myocardial infarction?
Does overexpression of SDF-1α improve cardiac stem cell migration, engraftment, and reduce infarcted size in a mouse model of myocardial infarction?
Absolute Event Rate: 17.3% vs 27.3%
p-value: p=<0.05
Overexpression of SDF-1α enhances cardiac stem cell migration and engraftment while reducing infarct size via the CXCR4/PI3K pathway in a preclinical myocardial infarction model.
Hypothesis-generating for SDF-1α in stem cell therapy; leaves open translation to human MI.
Cardiac stem cells (CSCs) can home to the infarcted area and regenerate myocardium. Stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 (SDF-1α/CXCR4) axis is pivotal in inducing CSCs migration. However, the mechanisms remain unclear. This study set out to detect if SDF-1α promotes migration and engraftment of CSCs through the CXCR4/PI3K (phosphatidylinositol 3-kinase) pathway. In the in vitro experiment, c-kit+ cells were isolated from neonatal mouse heart fragment culture by magnetic cell sorting. Fluorescence-activated cell sorting results demonstrated that a few c-kit+ cells expressed CD45 (4.54%) and Sca-1 (2.58%), the hematopoietic stem cell marker. Conditioned culture could induce c-kit+ cells multipotent differentiation, which was confirmed by cardiac troponin I (cTn-I), α-smooth muscle actin (α-SMA), and von Willebrand factor (vWF) staining. In vitro chemotaxis assays were performed using Transwell cell chambers to detect CSCs migration. The results showed that the cardiomyocytes infected with rAAV1-SDF-1α-eGFP significantly increased SDF-1α concentration, 5-fold more in supernatant than that in the control group, and subsequently attracted more CSCs migration. This effect was diminished by administration of AMD3100 (10 µg/ml, CXCR4 antagonist) or LY294002 (20 µmol/L, PI3K inhibitor). In myocardial infarction mice, overexpression of SDF-1α in the infarcted area by rAAV1-SDF-1α-eGFP infection resulted in more CSCs retention to the infarcted myocardium, a higher percentage of proliferation, and reduced infarcted area which was attenuated by AMD3100 or ly294002 pretreatment. These results indicated that overexpression of SDF-1α enhanced CSCs migration in vitro and engraftment of transplanted CSCs and reduced infarcted size via CXCR4/PI3K pathway.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2012) studied Myocardial infarction. rAAV1-SDF-1α-eGFP and c-kit+ CSCs vs. Empty vector and c-kit+ CSCs or MI alone was evaluated on Infarcted size (p=<0.05). Overexpression of SDF-1α enhanced cardiac stem cell migration and engraftment, significantly reducing infarcted size to 17.3% compared to 27.3% in the MI control group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: